Pulmonary Langerhans cell histiocytosis, acute myeloid leukemia, and myelofibrosis in a large family and review of the literature

被引:7
作者
Blakley, Matthew P. [1 ,2 ,3 ]
Dutcher, Janice P. [1 ]
Wiernik, Peter H. [1 ,4 ]
机构
[1] Canc Res Fdn New York, New York, NY USA
[2] Cornell Univ, Coll Human Ecol, Ithaca, NY 14853 USA
[3] 730 Univ Ave, Ithaca, NY 14850 USA
[4] 43 Longview Lane, Chappaqua, NY 10514 USA
关键词
Langerhans cell histiocytosis; Acute myeloid leukemia; Idiopathic myelofibrosis; Familial; Genetic; ACUTE PROMYELOCYTIC LEUKEMIA; LETTERER-SIWE DISEASE; EOSINOPHILIC GRANULOMA; SECONDARY LEUKEMIA; ASSOCIATION; ANTICIPATION; ETOPOSIDE; MALIGNANCY; ADULT;
D O I
10.1016/j.leukres.2018.01.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: There is mounting evidence that Langerhans cell histiocytosis (LCH) and acute myeloid leukemia (AML) are hematopoietic neoplasms that arise from the same myeloid precursor cell. In addition, studies suggest a relationship between LCH and primary idiopathic myelofibrosis (MF). Furthermore familial LCH, AML, and MF have each been reported. Methods: We examined more than 750 pedigrees of familial hematologic malignancies for evidence of familial LCH, AML, and/or MF and identified one family with all three neoplasms, which is presented here. Findings: In four generations of this large family there are five cases of AML in three generations, two cases of LCH in two generations and three cases of MF in two generations. Anticipation of -18 and -6 years was present in the patients with MF, and -8 years in the patients with LCH. Anticipation was also identified between one AML patient pair in generations III and IV (-18 years) and three patients with AML in generations II, III, and IV (-5 years and -10 years). Interpretation: This is the first report of familial LCH, AML, and MF in one family. The pedigree suggests a common basis for these entities, which is further suggested by the presence of anticipation in the pedigree.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 63 条
[1]   Familial clustering of Langerhans cell histiocytosis [J].
Aricò, M ;
Nichols, K ;
Whitlock, JA ;
Arceci, R ;
Haupt, R ;
Mittler, U ;
Kühne, T ;
Lombardi, A ;
Ishii, E ;
Egeler, RM ;
Danesino, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (04) :883-888
[2]   LANGERHANS CELL HISTIOCYTOSIS AND ACUTE-LEUKEMIA - UNUSUAL ASSOCIATION IN 2 CASES [J].
ARICO, M ;
COMELLI, A ;
BOSSI, G ;
RAITERI, E ;
PIOMBO, M ;
EGELER, RM .
MEDICAL AND PEDIATRIC ONCOLOGY, 1993, 21 (04) :271-273
[3]  
Aricò M, 2001, MED PEDIATR ONCOL, V36, P314, DOI 10.1002/1096-911X(20010201)36:2<314::AID-MPO1072>3.0.CO
[4]  
2-1
[5]  
Aricò M, 2001, HAEMATOLOGICA, V86, P1009
[6]   Different manifestations of Langerhans cell histiocytosis affecting two members of a family [J].
Balikó, Z ;
Schreiner, M ;
Kishindy, KK ;
Hegedüs, G ;
Kosztolányi, G .
RESPIRATION, 2000, 67 (05) :583-+
[7]   Therapy-related acute promyelocytic leukemia [J].
Beaumont, M ;
Sanz, M ;
Carli, PM ;
Maloisel, F ;
Thomas, X ;
Detourmignies, L ;
Guerci, A ;
Gratecos, N ;
Rayon, C ;
Miguel, JS ;
Odriozola, J ;
Cahn, JY ;
Huguet, F ;
Vekhof, A ;
Stamatoulas, A ;
Dombret, H ;
Capote, F ;
Esteve, J ;
Stoppa, AM ;
Fenaux, P .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (11) :2123-2137
[8]  
BERNARD J, 1967, NOUV REV FR HEMATOL, V7, P499
[9]  
Bierman H.R., 1966, JAMA-J AM MED ASSOC, V196, P156
[10]  
Bonduel M, 1998, AM J HEMATOL, V59, P175, DOI 10.1002/(SICI)1096-8652(199810)59:2<175::AID-AJH13>3.0.CO